Q2 2017 13F Holders as of 6/30/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
71.9M
-
Number of holders
-
308
-
Total 13F shares, excl. options
-
67.2M
-
Shares change
-
+1.24M
-
Total reported value, excl. options
-
$6.36B
-
Value change
-
+$125M
-
Put/Call ratio
-
0.42
-
Number of buys
-
183
-
Number of sells
-
-114
-
Price
-
$94.52
Significant Holders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) as of Q2 2017
337 filings reported holding WST - WEST PHARMACEUTICAL SERVICES INC - Common Stock as of Q2 2017.
WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) has 308 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 67.2M shares
of 71.9M outstanding shares and own 93.48% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (9.29M shares), VANGUARD GROUP INC (6.56M shares), BlackRock Inc. (6.22M shares), FRANKLIN RESOURCES INC (3.93M shares), Neuberger Berman Group LLC (3.75M shares), Select Equity Group, L.P. (3.14M shares), STATE STREET CORP (2.51M shares), JPMORGAN CHASE & CO (2.01M shares), BAMCO INC /NY/ (1.81M shares), and EAGLE ASSET MANAGEMENT INC (1.1M shares).
This table shows the top 308 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.